Centiva Capital, LP Gilead Sciences, Inc. Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

A detailed history of Centiva Capital, LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 17,611 shares of GILD stock, worth $1.62 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

17,611

Previous 5,700 208.96%

Holding current value

$1.62 Million

Previous $391,000 277.49%

% of portfolio

0.03%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $1.12 Million - $1.42 Million	16,884 Added 2322.42%	17,611 $1.48 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $331,663 - $382,765	-5,252 Reduced 87.84%	727 $49,000
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $288,753 - $352,127	4,034 Added 207.4%	5,979 $437,000
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $150,496 - $170,666	-2,054 Reduced 51.36%	1,945 $157,000
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $249,547 - $272,261	3,375 Added 540.87%	3,999 $299,000
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $5.46 Million - $6.22 Million	-71,776 Reduced 99.14%	624 $48,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $2.67 Million - $3.05 Million	34,579 Added 91.43%	72,400 $6.01 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $2.09 Million - $2.99 Million	33,463 Added 767.85%	37,821 $3.25 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $259,475 - $296,387	4,358 New	4,358 $269,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $4.9 Million - $5.52 Million	84,943 Added 313.94%	112,000 $6.92 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.13 Million - $1.42 Million	19,547 Added 260.28%	27,057 $1.61 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $181,409 - $195,720	-2,680 Reduced 26.3%	7,510 $525,000
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $418,260 - $477,234	-6,971 Reduced 40.62%	10,190 $659,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $500,219 - $569,976	8,830 Added 105.99%	17,161 $1 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $58,187 - $73,160	937 Added 12.67%	8,331 $526,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $1.12 Million - $1.3 Million	-15,476 Reduced 67.67%	7,394 $569,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $150,845 - $165,925	2,448 Added 11.99%	22,870 $1.49 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $275,731 - $304,359	4,411 Added 27.55%	20,422 $1.29 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $675,867 - $757,907	10,924 Added 214.74%	16,011 $1.08 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $2.53 Million - $2.84 Million	-40,493 Reduced 88.84%	5,087 $331,000
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $958,650 - $1.25 Million	15,835 Added 53.24%	45,580 $2.85 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $2.1 Million - $2.32 Million	29,445 Added 9815.0%	29,745 $2.3 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $21,852 - $26,640	300 New	300 $23,000

Others Institutions Holding GILD

# of Institutions

1,917

Shares Held

995M

Call Options Held

10.1M

Put Options Held

9.46M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account

Centiva Capital, LP Gilead Sciences, Inc. Transaction History